HALO · earnings call history
Halozyme Q2 FY26 — Record Royalty Growth and New Deal Momentum
Read the briefHalozyme Q1 FY26 — Strong Royalty Growth and Reaffirmed Guidance, New Buyback Program
Read the briefBrowse all US companies on the earnings-call register.